A study of the reproducibility of articulator settings from graphic records of mandibular movement.

D. Watt

Abstract:

What problem does this paper attempt to address?

Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patients

Giorgio Maria Masci,Guillaume Chassagnon,Marco Alifano,Camille Tlemsani,Pascaline Boudou-Rouquette,Giuseppe La Torre,Arvin Calinghen,Emma Canniff,Ludovic Fournel,Marie-Pierre Revel

DOI: https://doi.org/10.1016/j.ejrad.2024.111667

Abstract:Objectives: To evaluate the performance of artificial intelligence (AI) in the preoperative detection of lung metastases on CT. Materials and methods: Patients who underwent lung metastasectomy in our institution between 2016 and 2020 were enrolled, their preoperative CT reports having been performed before an AI solution (Veye Lung Nodules, version 3.9.2, Aidence) became available as a second reader in our department. All CT scans were retrospectively processed by AI. The sensitivities of unassisted radiologists (original CT radiology reports), AI reports alone and both combined were compared. Ground truth was established by a consensus reading of two radiologists, who analyzed whether the nodules mentioned in the pathology report were retrospectively visible on CT. Multivariate analysis was performed to identify nodule characteristics associated with detectability. Results: A total of 167 patients (men: 62.9 %; median age, 59 years [47-68]) with 475 resected nodules were included. AI detected an average of 4 nodules (0-17) per CT, of which 97 % were true nodules. The combination of radiologist plus AI (92.4 %) had significantly higher sensitivity than unassisted radiologists (80.4 %) (p < 0.001). In 27/57 (47.4 %) patients who had multiple preoperative CT scans, AI detected lung nodules earlier than the radiologist. Vascular contact was associated with non-detection by radiologists (OR:0.32[0.19, 0.54], p < 0.001), whilst the presence of cavitation (OR:0.26[0.13, 0.54], p < 0.001) or pleural contact (OR:0.10[0.04, 0.22], p < 0.001) was associated with non-detection by AI. Conclusion: AI significantly increases the sensitivity of preoperative detection of lung metastases and enables earlier detection, with a significant potential benefit for patient management.
The Use of Artificial Intelligence in the Differentiation of Malignant and Benign Lung Nodules on Computed Tomograms Proven by Surgical Pathology

Yung-Liang Wan,Pei-Kwei Tsay,Kuang-Tse Pan,Nguyen Ngoc Trang,Patricia Wanping Wu,Pei-Ching Huang,Wen-Yu Chuang,Ching-Yang Wu,ShihChung Benedict Lo,Patricia Wu,Nguyen Trang,ShihChung Lo

DOI: https://doi.org/10.3390/cancers12082211

2020-08-07

Cancers

Abstract:The purpose of this work was to evaluate the performance of an existing commercially available artificial intelligence (AI) software system in differentiating malignant and benign lung nodules. The AI tool consisted of a vessel-suppression function and a deep-learning-based computer-aided-detection (VS-CAD) analyzer. Fifty patients (32 females, mean age 52 years) with 75 lung nodules (47 malignant and 28 benign) underwent low-dose computed tomography (LDCT) followed by surgical excision and the pathological analysis of their 75 nodules within a 3 month time frame. All 50 cases were then processed by the AI software to generate corresponding VS images and CAD outcomes. All 75 pathologically proven lung nodules were well delineated by vessel-suppressed images. Three (6.4%) of the 47 lung cancer cases, and 11 (39.3%) of the 28 benign nodules were ignored and not detected by the AI without showing a CAD analysis summary. The AI system/radiologists produced a sensitivity and specificity (shown in %) of 93.6/89.4 and 39.3/82.1 in distinguishing malignant from benign nodules, respectively. AI sensitivity was higher than that of radiologists, though not statistically significant (p = 0.712). Specificity obtained by the radiologists was significantly higher than that of the VS-CAD AI (p = 0.003). There was no significant difference between the malignant and benign lesions with respect to age, gender, pure ground-glass pattern, the diameter and location of the nodules, or nodules <6 vs. ≥6 mm. However, more part-solid nodules were proven to be malignant than benign (90.9% vs. 9.1%), and more solid nodules were proven to be benign than malignant (86.7% vs. 13.3%) with statistical significance (p = 0.001 and <0.001, respectively). A larger cohort and prospective study are required to validate the AI performance.

oncology
Incidentally found resectable lung cancer with the usage of artificial intelligence on chest radiographs

Eun-Kyung Kim,Myung Hyun Kim,Eun Hye Lee,Hyun Joo Shin,Se Hyun Kwak

DOI: https://doi.org/10.1371/journal.pone.0281690

IF: 3.7

2023-03-10

PLoS ONE

Abstract:Purpose Detection of early lung cancer using chest radiograph remains challenging. We aimed to highlight the benefit of using artificial intelligence (AI) in chest radiograph with regard to its role in the unexpected detection of resectable early lung cancer. Materials and methods Patients with pathologically proven resectable lung cancer from March 2020 to February 2022 were retrospectively analyzed. Among them, we included patients with incidentally detected resectable lung cancer. Because commercially available AI-based lesion detection software was integrated for all chest radiographs in our hospital, we reviewed the clinical process of detecting lung cancer using AI in chest radiographs. Results Among the 75 patients with pathologically proven resectable lung cancer, 13 (17.3%) had incidentally discovered lung cancer with a median size of 2.6 cm. Eight patients underwent chest radiograph for the evaluation of extrapulmonary diseases, while five underwent radiograph in preparation of an operation or procedure concerning other body parts. All lesions were detected as nodules by the AI-based software, and the median abnormality score for the nodules was 78%. Eight patients (61.5%) consulted a pulmonologist promptly on the same day when the chest radiograph was taken and before they received the radiologist’s official report. Total and invasive sizes of the part-solid nodules were 2.3–3.3 cm and 0.75–2.2 cm, respectively. Conclusion This study demonstrates actual cases of unexpectedly detected resectable early lung cancer using AI-based lesion detection software. Our results suggest that AI is beneficial for incidental detection of early lung cancer in chest radiographs.

multidisciplinary sciences
Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial

Heng-Sheng Chao,Chiao-Yun Tsai,Chung-Wei Chou,Tsu-Hui Shiao,Hsu-Chih Huang,Kun-Chieh Chen,Hao-Hung Tsai,Chin-Yu Lin,Yuh-Min Chen

DOI: https://doi.org/10.3390/biomedicines11010147

IF: 4.757

2023-01-07

Biomedicines

Abstract:Low-dose computed tomography (LDCT) has emerged as a standard method for detecting early-stage lung cancer. However, the tedious computer tomography (CT) slide reading, patient-by-patient check, and lack of standard criteria to determine the vague but possible nodule leads to variable outcomes of CT slide interpretation. To determine the artificial intelligence (AI)-assisted CT examination, AI algorithm-assisted CT screening was embedded in the hospital picture archiving and communication system, and a 200 person-scaled clinical trial was conducted at two medical centers. With AI algorithm-assisted CT screening, the sensitivity of detecting nodules sized 4–5 mm, 6~10 mm, 11~20 mm, and >20 mm increased by 41%, 11.2%, 10.3%, and 18.7%, respectively. Remarkably, the overall sensitivity of detecting varied nodules increased by 20.7% from 67.7% to 88.4%. Furthermore, the sensitivity increased by 18.5% from 72.5% to 91% for detecting ground glass nodules (GGN), which is challenging for radiologists and physicians. The free-response operating characteristic (FROC) AI score was ≥0.4, and the AI algorithm standalone CT screening sensitivity reached >95% with an area under the localization receiver operating characteristic curve (LROC-AUC) of >0.88. Our study demonstrates that AI algorithm-embedded CT screening significantly ameliorates tedious LDCT practices for doctors.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Molecular forces caused by the confinement of thermal noise.

M. Morariu,E. Schäffer,U. Steiner

DOI: https://doi.org/10.1103/PHYSREVLETT.92.156102

IF: 8.6

2004-04-16

Physical Review Letters

Abstract:We have investigated spontaneous surface instabilities of very thin polymer films. Film stability and the wavelength of the dominating unstable mode were found to depend sensitively on the media adjacent to the film. Our experimental results cannot be explained by van der Waals interactions alone. To account for the presence of an additional destabilizing force, we propose that the geometrical confinement of thermally excited acoustic waves gives rise to a force that is strong enough to destabilize thin films. This thermoacoustic effect is of similar magnitude as van der Waals forces.
Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value

Jordan Chamberlin,Madison R. Kocher,Jeffrey Waltz,Madalyn Snoddy,Natalie F. C. Stringer,Joseph Stephenson,Pooyan Sahbaee,Puneet Sharma,Saikiran Rapaka,U. Joseph Schoepf,Andres F. Abadia,Jonathan Sperl,Phillip Hoelzer,Megan Mercer,Nayana Somayaji,Gilberto Aquino,Jeremy R. Burt

DOI: https://doi.org/10.1186/s12916-021-01928-3

IF: 9.3

2021-03-04

BMC Medicine

Abstract:Abstract Background Artificial intelligence (AI) in diagnostic radiology is undergoing rapid development. Its potential utility to improve diagnostic performance for cardiopulmonary events is widely recognized, but the accuracy and precision have yet to be demonstrated in the context of current screening modalities. Here, we present findings on the performance of an AI convolutional neural network (CNN) prototype (AI-RAD Companion, Siemens Healthineers) that automatically detects pulmonary nodules and quantifies coronary artery calcium volume (CACV) on low-dose chest CT (LDCT), and compare results to expert radiologists. We also correlate AI findings with adverse cardiopulmonary outcomes in a retrospective cohort of 117 patients who underwent LDCT. Methods A total of 117 patients were enrolled in this study. Two CNNs were used to identify lung nodules and CACV on LDCT scans. All subjects were used for lung nodule analysis, and 96 subjects met the criteria for coronary artery calcium volume analysis. Interobserver concordance was measured using ICC and Cohen’s kappa. Multivariate logistic regression and partial least squares regression were used for outcomes analysis. Results Agreement of the AI findings with experts was excellent (CACV ICC = 0.904, lung nodules Cohen’s kappa = 0.846) with high sensitivity and specificity (CACV: sensitivity = .929, specificity = .960; lung nodules: sensitivity = 1, specificity = 0.708). The AI findings improved the prediction of major cardiopulmonary outcomes at 1-year follow-up including major adverse cardiac events and lung cancer (AUC MACE = 0.911, AUC Lung Cancer = 0.942). Conclusion We conclude the AI prototype rapidly and accurately identifies significant risk factors for cardiopulmonary disease on standard screening low-dose chest CT. This information can be used to improve diagnostic ability, facilitate intervention, improve morbidity and mortality, and decrease healthcare costs. There is also potential application in countries with limited numbers of cardiothoracic radiologists.

medicine, general & internal
Deep Learning-based Artificial Intelligence Improves Accuracy of Error-prone Lung Nodules

Chou-Chin Lan,Min-Shiau Hsieh,Jong-Kai Hsiao,Chih-Wei Wu,Hao-Hsiang Yang,Yi Chen,Po-Chun Hsieh,I-Shiang Tzeng,Yao-Kuang Wu

DOI: https://doi.org/10.7150/ijms.69400

2022-01-01

International Journal of Medical Sciences

Abstract:Introduction: Early detection of lung cancer is one way to improve outcomes. Improving the detection of nodules on chest CT scans is important. Previous artificial intelligence (AI) modules show rapid advantages, which improves the performance of detecting lung nodules in some datasets. However, they have a high false-positive (FP) rate. Its effectiveness in clinical practice has not yet been fully proven. We aimed to use AI assistance in CT scans to decrease FP. Materials and methods: CT images of 60 patients were obtained. Five senior doctors who were blinded to these cases participated in this study for the detection of lung nodules. Two doctors performed manual detection and labeling of lung nodules without AI assistance. Another three doctors used AI assistance to detect and label lung nodules before manual interpretation. The AI program is based on a deep learning framework. Results: In total, 266 nodules were identified. For doctors without AI assistance, the FP was 0.617-0.650/scan and the sensitivity was 59.2-67.0%. For doctors with AI assistance, the FP was 0.067 to 0.2/scan and the sensitivity was 59.2-77.3% This AI-assisted program significantly reduced FP. The error-prone characteristics of lung nodules were central locations, ground-glass appearances, and small sizes. The AI-assisted program improved the detection of error-prone nodules. Conclusions: Detection of lung nodules is important for lung cancer treatment. When facing a large number of CT scans, error-prone nodules are a great challenge for doctors. The AI-assisted program improved the performance of detecting lung nodules, especially for error-prone nodules.

medicine, general & internal
Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies

Julia Geppert,Asra Asgharzadeh,Anna Brown,Chris Stinton,Emma J Helm,Surangi Jayakody,Daniel Todkill,Daniel Gallacher,Hesam Ghiasvand,Mubarak Patel,Peter Auguste,Alexander Tsertsvadze,Yen-Fu Chen,Amy Grove,Bethany Shinkins,Aileen Clarke,Sian Taylor-Phillips

DOI: https://doi.org/10.1136/thorax-2024-221662

2024-10-17

Thorax

Abstract:Objectives To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT. Methods A systematic review of CE-marked, AI-based software for automated detection and analysis of nodules in CT lung cancer screening was conducted. Multiple databases including Medline, Embase and Cochrane CENTRAL were searched from 2012 to March 2023. Primary research reporting test accuracy or impact on reading time or clinical management was included. QUADAS-2 and QUADAS-C were used to assess risk of bias. We undertook narrative synthesis. Results Eleven studies evaluating six different AI-based software and reporting on 19 770 patients were eligible. All were at high risk of bias with multiple applicability concerns. Compared with unaided reading, AI-assisted reading was faster and generally improved sensitivity (+5% to +20% for detecting/categorising actionable nodules; +3% to +15% for detecting/categorising malignant nodules), with lower specificity (–7% to –3% for correctly detecting/categorising people without actionable nodules; –8% to –6% for correctly detecting/categorising people without malignant nodules). AI assistance tended to increase the proportion of nodules allocated to higher risk categories. Assuming 0.5% cancer prevalence, these results would translate into additional 150–750 cancers detected per million people attending screening but lead to an additional 59 700 to 79 600 people attending screening without cancer receiving unnecessary CT surveillance. Conclusions AI assistance in lung cancer screening may improve sensitivity but increases the number of false-positive results and unnecessary surveillance. Future research needs to increase the specificity of AI-assisted reading and minimise risk of bias and applicability concerns through improved study design. PROSPERO registration number CRD42021298449.

respiratory system
OP605 Artificial Intelligence Assisted Diagnosis Technology For Benign-Malignant Lung Nodule Classification On Computerized Tomography Images: A Meta-Analysis

Guo Huang,Yizhong Zhang,Di Xue

DOI: https://doi.org/10.1017/S0266462320001233

2020-01-01

International Journal of Technology Assessment in Health Care

Abstract:IntroductionArtificial Intelligence (AI) is an important product of the rapid development of computer technology today. It has a far-reaching impact on the development of medical diagnostic technology especially in combination with medical imaging. The aim of this study was to analyze the diagnostic accuracy of AI-assisted diagnosis technology for classification of benign and malignant lung nodules on Computerized Tomography (CT) images.MethodsA meta-analysis was conducted of published research articles on diagnostic accuracy of AI-assisted diagnosis technology for lung nodules classification between 2010 and 2019 in the databases of PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform and China Bio-medicine Database. Statistical analysis was performed with the software SAS 9.4 and Stata 12.0, and the summary receiver operating characteristic (SROC) curve was drawn to evaluate accuracy of the method.ResultsA total of 27 studies with 5,701 lung nodules were considered. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio and the area under the curve of SROC for AI-assisted diagnosis technology for lung nodules classification respectively were 0.892 (95% confidence interval [CI]: 0.854–0.920), 0.876 (95% CI: 0.833–0.909), 7.190 (95% CI: 5.194–9.955), 0.124 (95% CI: 0.089–0.171), 58.102 (95% CI: 32.391–104.219) and 0.95 (95%CI: 0.92–0.96).ConclusionsOf note, several limitations should be considered when interpreting the findings of this meta-analysis. Data acquisition is not comprehensive enough because the language of the literature search was limited to Chinese and English. Furthermore,heterogeneity caused due to the difference of lung nodule size affected the study results. Despite these limitations, our study suggests that AI-assisted diagnosis technology for benign-malignant lung nodule classification on CT images obtains high diagnostic accuracy, and it can be used as a novel method to differentiate benign and malignant pulmonary nodules.
Public awareness of aortic aneurysm.

M. Tilson

DOI: https://doi.org/10.1016/S0967-2109(01)00014-X

2001-08-01

Cardiovascular Surgery

Abstract:
Right-sided pacemaker-related endocarditis due to Acremonium species.

L. Heitmann,A. Cometta,M. Hurni,N. Aebischer,I. Tschan-Schild,J. Billé

DOI: https://doi.org/10.1086/516892

IF: 20.999

1997-07-01

Clinical Infectious Diseases

Abstract:P = .017). There were statistically significant differences between the patients with the CDAD and the carriers in terms of the presence of more than three active medical problems (i.e., requiring treatment in the ICU; 65% vs. 27%; P = .05), the presence of more than three underlying diseases (65% vs. 27%; P = .05), and longer duration of antibiotic therapy (88% vs. 45%; P = .02) (table 1). A total of 68 stool specimens were positive for C. difficile, and 62 of the isolates were preserved for further research. Fifty-nine (95%) of the 62 isolates, evenly distributed in CDAD group and carrier group, were positive for toxins. PCR ribotyping yielded five ribotypes, and the RAPD method yielded seven types. The combination of these two methods generated eight distinctive fingerprints. The most frequently isolated type was type I (isolated from 29 [47%] of 62 patients), which could be isolated from nine (53%) of 17 patients with CDAD and from two (18%) of 11 asymptomatic carriers (P = .08). In addition, types II, III, IV, and V were variably associated with diseases. Types VI, VII, and VIII were recovered only from asymptomatic carriers, but the numbers of isolates of these types were small. Our data show that there was no correlation between genotypes, toxin production, and clinical manifestations of infection. There was no strain-specific difference for asymptomatic carriers vs. patients with CDAD. The predominant type (type I) was variably associated with diseases, and five of eight types were associated with diarrhea. Toxigenic C. difficile strains could be isolated both from patients with CDAD and from asymptomatic carriers. Actually, most strains from both groups were toxigenic in vitro. The results of our study also failed to support the belief that the pathogenicity of an isolate depended on strain variation and toxin production. Host factors, especially debilitat d status, appear to be important determ nants fo the clinical expr ssion of CDAD.
Artificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid

Hyung Kyung Kim,Eunkyung Han,Jeonghyo Lee,Kwangil Yim,Jamshid Abdul-Ghafar,Kyung Jin Seo,Jang Won Seo,Gyungyub Gong,Nam Hoon Cho,Milim Kim,Chong Woo Yoo,Yosep Chong

DOI: https://doi.org/10.3390/cancers16051064

2024-03-06

Cancers

Abstract:Ascites cytology is a cost-effective test for metastatic colorectal cancer (CRC) in the abdominal cavity. However, metastatic carcinoma of the peritoneum is difficult to diagnose based on biopsy findings, and ascitic aspiration cytology has a low sensitivity and specificity and a high inter-observer variability. The aim of the present study was to apply artificial intelligence (AI) to classify benign and malignant cells in ascites cytology patch images of metastatic CRC using a deep convolutional neural network. Datasets were collected from The OPEN AI Dataset Project, a nationwide cytology dataset for AI research. The numbers of patch images used for training, validation, and testing were 56,560, 7068, and 6534, respectively. We evaluated 1041 patch images of benign and metastatic CRC in the ascitic fluid to compare the performance of pathologists and an AI algorithm, and to examine whether the diagnostic accuracy of pathologists improved with the assistance of AI. This AI method showed an accuracy, a sensitivity, and a specificity of 93.74%, 87.76%, and 99.75%, respectively, for the differential diagnosis of malignant and benign ascites. The diagnostic accuracy and sensitivity of the pathologist with the assistance of the proposed AI method increased from 86.8% to 90.5% and from 73.3% to 79.3%, respectively. The proposed deep learning method may assist pathologists with different levels of experience in diagnosing metastatic CRC cells of ascites.

oncology
Can Artificial Intelligence Replace Humans for Detecting Lung Tumors on Radiographs? An Examination of Resected Malignant Lung Tumors

Rurika Hamanaka,Makoto Oda

DOI: https://doi.org/10.3390/jpm14020164

IF: 3.5083

2024-02-01

Journal of Personalized Medicine

Abstract:Objective: Although lung cancer screening trials have showed the efficacy of computed tomography to decrease mortality compared with chest radiography, the two are widely taken as different kinds of clinical practices. Artificial intelligence can improve outcomes by detecting lung tumors in chest radiographs. Currently, artificial intelligence is used as an aid for physicians to interpret radiograms, but with the future evolution of artificial intelligence, it may become a modality that replaces physicians. Therefore, in this study, we investigated the current situation of lung cancer diagnosis by artificial intelligence. Methods: In total, we recruited 174 consecutive patients with malignant pulmonary tumors who underwent surgery after chest radiography that was checked by artificial intelligence before surgery. Artificial intelligence diagnoses were performed using the medical image analysis software EIRL X-ray Lung Nodule version 1.12, (LPIXEL Inc., Tokyo, Japan). Results: The artificial intelligence determined pulmonary tumors in 90 cases (51.7% for all patients and 57.7% excluding 18 patients with adenocarcinoma in situ). There was no significant difference in the detection rate by the artificial intelligence among histological types. All eighteen cases of adenocarcinoma in situ were not detected by either the artificial intelligence or the physicians. In a univariate analysis, the artificial intelligence could detect cases with larger histopathological tumor size (p < 0.0001), larger histopathological invasion size (p < 0.0001), and higher maximum standardized uptake values of positron emission tomography-computed tomography (p < 0.0001). In a multivariate analysis, detection by AI was significantly higher in cases with a large histopathological invasive size (p = 0.006). In 156 cases excluding adenocarcinoma in situ, we examined the rate of artificial intelligence detection based on the tumor site. Tumors in the lower lung field area were less frequently detected (p = 0.019) and tumors in the middle lung field area were more frequently detected (p = 0.014) compared with tumors in the upper lung field area. Conclusions: Our study showed that using artificial intelligence, the diagnosis of tumor-associated findings and the diagnosis of areas that overlap with anatomical structures is not satisfactory. While the current standing of artificial intelligence diagnostics is to assist physicians in making diagnoses, there is the possibility that artificial intelligence can substitute for humans in the future. However, artificial intelligence should be used in the future as an enhancement, to aid physicians in the role of a radiologist in the workflow.

medicine, general & internal,health care sciences & services
Application of CT and MRI images based on artificial intelligence to predict lymph node metastases in patients with oral squamous cell carcinoma: a subgroup meta-analysis

Cheng Deng,Jun Hu,Ping Tang,Tao Xu,Ling He,Zesheng Zeng,Jianfeng Sheng

DOI: https://doi.org/10.3389/fonc.2024.1395159

IF: 4.7

2024-06-19

Frontiers in Oncology

Abstract:Background: The performance of artificial intelligence (AI) in the prediction of lymph node (LN) metastasis in patients with oral squamous cell carcinoma (OSCC) has not been quantitatively evaluated. The purpose of this study was to conduct a systematic review and meta-analysis of published data on the diagnostic performance of CT and MRI based on AI algorithms for predicting LN metastases in patients with OSCC. Methods: We searched the Embase, PubMed (Medline), Web of Science, and Cochrane databases for studies on the use of AI in predicting LN metastasis in OSCC. Binary diagnostic accuracy data were extracted to obtain the outcomes of interest, namely, the area under the curve (AUC), sensitivity, and specificity, and compared the diagnostic performance of AI with that of radiologists. Subgroup analyses were performed with regard to different types of AI algorithms and imaging modalities. Results: Fourteen eligible studies were included in the meta-analysis. The AUC, sensitivity, and specificity of the AI models for the diagnosis of LN metastases were 0.92 (95% CI 0.89–0.94), 0.79 (95% CI 0.72–0.85), and 0.90 (95% CI 0.86–0.93), respectively. Promising diagnostic performance was observed in the subgroup analyses based on algorithm types [machine learning (ML) or deep learning (DL)] and imaging modalities (CT vs. MRI). The pooled diagnostic performance of AI was significantly better than that of experienced radiologists. Discussion: In conclusion, AI based on CT and MRI imaging has good diagnostic accuracy in predicting LN metastasis in patients with OSCC and thus has the potential for clinical application. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/#recordDetails, PROSPERO (No. CRD42024506159).

oncology
Performance of artificial intelligence-based software for the automatic detection of lung lesions on chest radiographs of patients with suspected lung cancer

Atsushi Takamatsu,Midori Ueno,Kotaro Yoshida,Takeshi Kobayashi,Satoshi Kobayashi,Toshifumi Gabata

DOI: https://doi.org/10.1007/s11604-023-01503-1

2023-11-30

Japanese Journal of Radiology

Abstract:Abstract Purpose This study aimed to evaluate the performance of the commercially available artificial intelligence-based software CXR-AID for the automatic detection of pulmonary nodules on the chest radiographs of patients suspected of having lung cancer. Materials and methods This retrospective study included 399 patients with clinically suspected lung cancer who underwent CT and chest radiography within 1 month between June 2020 and May 2022. The candidate areas on chest radiographs identified by CXR-AID were categorized into target (properly detected areas) and non-target (improperly detected areas) areas. The non-target areas were further divided into non-target normal areas (false positives for normal structures) and non-target abnormal areas. The visibility score, characteristics and location of the nodules, presence of overlapping structures, and background lung score and presence of pulmonary disease were manually evaluated and compared between the nodules detected or undetected by CXR-AID. The probability indices calculated by CXR-AID were compared between the target and non-target areas. Results Among the 450 nodules detected in 399 patients, 331 nodules detected in 313 patients were visible on chest radiographs during manual evaluation. CXR-AID detected 264 of these 331 nodules with a sensitivity of 0.80. The detection sensitivity increased significantly with the visibility score. No significant correlation was observed between the background lung score and sensitivity. The non-target area per image was 0.85, and the probability index of the non-target area was lower than that of the target area. The non-target normal area per image was 0.24. Larger and more solid nodules exhibited higher sensitivities, while nodules with overlapping structures demonstrated lower detection sensitivities. Conclusion The nodule detection sensitivity of CXR-AID on chest radiographs was 0.80, and the non-target and non-target normal areas per image were 0.85 and 0.24, respectively. Larger, solid nodules without overlapping structures were detected more readily by CXR-AID.

radiology, nuclear medicine & medical imaging
Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis

Wu Quanyang,Huang Yao,Wang Sicong,Qi Linlin,Zhang Zewei,Hou Donghui,Li Hongjia,Zhao Shijun

DOI: https://doi.org/10.1002/cam4.7140

IF: 4.711

2024-04-07

Cancer Medicine

Abstract:Background The exceptional capabilities of artificial intelligence (AI) in extracting image information and processing complex models have led to its recognition across various medical fields. With the continuous evolution of AI technologies based on deep learning, particularly the advent of convolutional neural networks (CNNs), AI presents an expanded horizon of applications in lung cancer screening, including lung segmentation, nodule detection, false‐positive reduction, nodule classification, and prognosis. Methodology This review initially analyzes the current status of AI technologies. It then explores the applications of AI in lung cancer screening, including lung segmentation, nodule detection, and classification, and assesses the potential of AI in enhancing the sensitivity of nodule detection and reducing false‐positive rates. Finally, it addresses the challenges and future directions of AI in lung cancer screening. Results AI holds substantial prospects in lung cancer screening. It demonstrates significant potential in improving nodule detection sensitivity, reducing false‐positive rates, and classifying nodules, while also showing value in predicting nodule growth and pathological/genetic typing. Conclusions AI offers a promising supportive approach to lung cancer screening, presenting considerable potential in enhancing nodule detection sensitivity, reducing false‐positive rates, and classifying nodules. However, the universality and interpretability of AI results need further enhancement. Future research should focus on the large‐scale validation of new deep learning‐based algorithms and multi‐center studies to improve the efficacy of AI in lung cancer screening.

oncology
Impact of AI-assisted CXR analysis in detecting incidental lung nodules and lung cancers in non-respiratory outpatient clinics

Se Hyun Kwak,Kyeong Yeon Kim,Ji Soo Choi,Min Chul Kim,Chang Hwan Seol,Sung Ryeol Kim,Eun Hye Lee

DOI: https://doi.org/10.3389/fmed.2024.1449537

2024-08-07

Abstract:Purpose: The use of artificial intelligence (AI) for chest X-ray (CXR) analysis is becoming increasingly prevalent in medical environments. This study aimed to determine whether AI in CXR can unexpectedly detect lung nodule detection and influence patient diagnosis and management in non-respiratory outpatient clinics. Methods: In this retrospective study, patients over 18 years of age, who underwent CXR at Yongin Severance Hospital outpatient clinics between March 2021 and January 2023 and were identified to have lung nodules through AI software, were included. Commercially available AI-based lesion detection software (Lunit INSIGHT CXR) was used to detect lung nodules. Results: Out Of 56,802 radiographic procedures, 40,191 were from non-respiratory departments, with AI detecting lung nodules in 1,754 cases (4.4%). Excluding 139 patients with known lung lesions, 1,615 patients were included in the final analysis. Out of these, 30.7% (495/1,615) underwent respiratory consultation and 31.7% underwent chest CT scans (512/1,615). As a result of the CT scans, 71.5% (366 cases) were found to have true nodules. Among these, the final diagnoses included 36 lung cancers (7.0%, 36/512), 141 lung nodules requiring follow-up (27.5%, 141/512), 114 active pulmonary infections (22.3%, 114/512), and 75 old inflammatory sequelae (14.6%, 75/512). The mean AI nodule score for lung cancer was significantly higher than that for other nodules (56.72 vs. 33.44, p < 0.001). Additionally, active pulmonary infection had a higher consolidation score, and old inflammatory sequelae had the highest fibrosis score, demonstrating differences in the AI analysis among the final diagnosis groups. Conclusion: This study indicates that AI-detected incidental nodule abnormalities on CXR in non-respiratory outpatient clinics result in a substantial number of clinically significant diagnoses, emphasizing AI's role in detecting lung nodules and need for further evaluation and specialist consultation for proper diagnosis and management.
Artificial intelligence–based prediction of cervical lymph node metastasis in papillary thyroid cancer with CT

Cai Wang,Pengyi Yu,Haicheng Zhang,Xiao Han,Zheying Song,Guibin Zheng,Guangkuo Wang,Haitao Zheng,Ning Mao,Xicheng Song

DOI: https://doi.org/10.1007/s00330-023-09700-2

IF: 7.034

2023-05-13

European Radiology

Abstract:ObjectivesTo develop an artificial intelligence (AI) system for predicting cervical lymph node metastasis (CLNM) preoperatively in patients with papillary thyroid cancer (PTC) based on CT images.MethodsThis multicenter retrospective study included the preoperative CT of PTC patients who were divided into the development, internal, and external test sets. The region of interest of the primary tumor was outlined manually on the CT images by a radiologist who has eight years of experience. With the use of the CT images and lesions masks, the deep learning (DL) signature was developed by the DenseNet combined with convolutional block attention module. One-way analysis of variance and least absolute shrinkage and selection operator were used to select features, and a support vector machine was used to construct the radiomics signature. Random forest was used to combine the DL, radiomics, and clinical signature to perform the final prediction. The receiver operating characteristic curve, sensitivity, specificity, and accuracy were used by two radiologists (R1 and R2) to evaluate and compare the AI system.ResultsFor the internal and external test set, the AI system achieved excellent performance with AUCs of 0.84 and 0.81, higher than the DL (p = .03, .82), radiomics (p < .001, .04), and clinical model (p < .001, .006). With the aid of the AI system, the specificities of radiologists were improved by 9% and 15% for R1 and 13% and 9% for R2, respectively.ConclusionsThe AI system can help predict CLNM in patients with PTC, and the radiologists’ performance improved with AI assistance.Clinical relevance statementThis study developed an AI system for preoperative prediction of CLNM in PTC patients based on CT images, and the radiologists’ performance improved with AI assistance, which could improve the effectiveness of individual clinical decision-making.Key Points• This multicenter retrospective study showed that the preoperative CT image-based AI system has the potential for predicting the CLNM of PTC.• The AI system was superior to the radiomics and clinical model in predicting the CLNM of PTC.• The radiologists’ diagnostic performance improved when they received the AI system assistance.

radiology, nuclear medicine & medical imaging
Using artificial intelligence based imaging to predict lymph node metastasis in non-small cell lung cancer: a systematic review and meta-analysis

Lujiao Chen,Bo Chen,Zhenhua Zhao,Liyijing Shen

DOI: https://doi.org/10.21037/qims-24-664

2024-10-01

Abstract:Background: Lung cancer, especially non-small cell lung cancer (NSCLC), is one of the most-deadly malignancies worldwide. Lung cancer has a worse 5-year survival rate than many primary malignancies. Thus, the early detection and prognosis prediction of lung cancer are crucial. The early detection and prognosis prediction of lung cancer have improved with the widespread use of artificial intelligence (AI) technologies. This meta-analysis examined the accuracy and efficacy of AI-based models in predicting lymph node metastasis (LNM) in NSCLC patients using imaging data. Our findings could help clinicians predict patient prognosis and select alternative therapies. Methods: We searched the PubMed, Web of Science, Cochrane Library, and Embase databases for relevant articles published up to January 31, 2024. Two reviewers individually evaluated all the retrieved articles to assess their eligibility for inclusion in the meta-analysis. The systematic assessment and meta-analysis comprised articles that satisfied the inclusion criteria (e.g., randomized or non-randomized trials, and observational studies) and exclusion criteria (e.g., articles not published in English), and provided data for the quantitative synthesis. The quality of the included articles was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). The pooled sensitivity, specificity, and area under the curve (AUC) were used to evaluate the ability of AI-based imaging models to predict LNM in NSCLC patients. Sources of heterogeneity were investigated using meta-regression. Covariates, including country, sample size, imaging modality, model validation technique, and model algorithm, were examined in the subgroup analysis. Results: The final meta-analysis comprised 11 retrospective studies of 6,088 NSCLC patients, of whom 1,483 had LNM. The pooled sensitivity, specificity, and AUC of the AI-based imaging model for predicting LNM in NSCLC patients were 0.87 [95% confidence interval (CI): 0.80-0.91], 0.85 (95% CI: 0.78-0.89), and 0.92 (95% CI: 0.90-0.94). Based on the QUADAS-2 results, a risk of bias was detected in the patient selection and diagnostic tests of the included articles. However, the quality of the included articles was generally acceptable. The pooled sensitivity and specificity were heterogeneous (I2>75%). The meta-regression and subgroup analyses showed that imaging modality [computed tomography (CT) or positron emission tomography (PET)/CT], and the neural network method model design significantly affected heterogeneity of this study. Models employing sample size data from a single center and the least absolute shrinkage and selection operator (LASSO) method had greater sensitivity than other techniques. Using the Deek' s funnel plot, no publishing bias was found. The results of the sensitivity analysis showed that deleting each article one by one did not change the findings. Conclusions: Imaging data models based on AI algorithms have good diagnostic accuracy in predicting LNM in patients with NSCLC and could be applied in clinical settings.
[Clinical and electroencephalographic evaluation of the action of Tegretol in cases of epilepsy].

M. Bittner-Manicka,R. Wasilewski,E. Lewicka

Neurologia i Neurochirurgia Polska

Abstract:

A study of the reproducibility of articulator settings from graphic records of mandibular movement.

Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patients

The Use of Artificial Intelligence in the Differentiation of Malignant and Benign Lung Nodules on Computed Tomograms Proven by Surgical Pathology

Incidentally found resectable lung cancer with the usage of artificial intelligence on chest radiographs

Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial

Molecular forces caused by the confinement of thermal noise.

Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value

Deep Learning-based Artificial Intelligence Improves Accuracy of Error-prone Lung Nodules

Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies

OP605 Artificial Intelligence Assisted Diagnosis Technology For Benign-Malignant Lung Nodule Classification On Computerized Tomography Images: A Meta-Analysis

Public awareness of aortic aneurysm.

Right-sided pacemaker-related endocarditis due to Acremonium species.

Artificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid

Can Artificial Intelligence Replace Humans for Detecting Lung Tumors on Radiographs? An Examination of Resected Malignant Lung Tumors

Application of CT and MRI images based on artificial intelligence to predict lymph node metastases in patients with oral squamous cell carcinoma: a subgroup meta-analysis

Performance of artificial intelligence-based software for the automatic detection of lung lesions on chest radiographs of patients with suspected lung cancer

Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis

Impact of AI-assisted CXR analysis in detecting incidental lung nodules and lung cancers in non-respiratory outpatient clinics

Artificial intelligence–based prediction of cervical lymph node metastasis in papillary thyroid cancer with CT

Using artificial intelligence based imaging to predict lymph node metastasis in non-small cell lung cancer: a systematic review and meta-analysis

[Clinical and electroencephalographic evaluation of the action of Tegretol in cases of epilepsy].